Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-164201
Filing Date
2026-04-20
Accepted
2026-04-20 17:00:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d138057d424b5.htm 424B5 488565
2 GRAPHIC g138057g02a02.jpg GRAPHIC 17867
3 GRAPHIC g138057g32t43.jpg GRAPHIC 18418
  Complete submission text file 0001193125-26-164201.txt   540028
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-291466 | Film No.: 26875815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)